CYCLOSPORINE-ASSOCIATED REDUCTION IN SYSTOLIC MYOCARDIAL-FUNCTION IN THE RAT

被引:22
作者
KINGMA, I
HARMSEN, E
TERKEURS, HEDJ
BENEDIKTSSON, H
PAUL, LC
机构
[1] UNIV CALGARY,FOOTHILLS GEN HOSP,DEPT MED,DIV NEPHROL,1403-29 ST NW,CALGARY T2N 2T9,ALBERTA,CANADA
[2] UNIV CALGARY,FOOTHILLS GEN HOSP,DEPT MED PHYSIOL,CALGARY T2N 1N4,ALBERTA,CANADA
[3] UNIV CALGARY,FOOTHILLS GEN HOSP,DEPT HISTOPATHOL,CALGARY T2N 1N4,ALBERTA,CANADA
关键词
CYCLOSPORINE; IMMUNOSUPPRESSION; HEART TRANSPLANTATION; MYOCARDIAL TOXICITY;
D O I
10.1016/0167-5273(91)90262-N
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The cardiotoxic effect of cyclosporine in the inbred rat was investigated in the isolated perfused heart model. Diastolic and systolic function was studied in 5 groups of (Lewis X Brown Norway)F1 rats treated with different doses of cyclosporine for different time intervals and in a group which received the vehiculum cremophor. Of the cyclosporine-treated rats, one group was studied four weeks after drug discontinuation to assess reversibility of the effect. To control for the nephrotoxic side effects of cyclosporine, a group of animals that had undergone 1.5-1.75 renal ablation was included. Left ventricular pressures were measured with a balloon catheter; stepwise increases in preload were obtained by small increments in the balloon volume. Over the range of left ventricular volumes studied, no differences were found in diastolic pressure between the groups. Peak systolic pressures were significantly lower in hearts obtained from cyclosporine treated rats which had received 15 or 7.5 mg/kg/24 h subcutaneously for three weeks (P < 0.05). Our results indicate that cyclosporine treatment resulted in a reversible decrease in myocardial contractile force apparently unrelated to decreases in renal function or to changes in mean arterial pressure.
引用
收藏
页码:15 / 22
页数:8
相关论文
共 35 条
[1]   CHARACTERIZATION OF OSCILLATIONS OF INTRACELLULAR CALCIUM-CONCENTRATION IN FERRET VENTRICULAR MUSCLE [J].
ALLEN, DG ;
EISNER, DA ;
ORCHARD, CH .
JOURNAL OF PHYSIOLOGY-LONDON, 1984, 352 (JUL) :113-128
[2]  
ALTURA B M, 1985, Magnesium, V4, P245
[3]  
BARTON CH, 1989, J LAB CLIN MED, V114, P232
[4]   SYSTEMIC HYPERTENSION AFTER CARDIAC TRANSPLANTATION - EFFECT OF CYCLOSPORINE ON THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM [J].
BELLET, M ;
CABROL, C ;
SASSANO, P ;
LEGER, P ;
CORVOL, P ;
MENARD, J .
AMERICAN JOURNAL OF CARDIOLOGY, 1985, 56 (15) :927-931
[5]   AUTOMATED PROCEDURE FOR QUANTITATIVE-DETERMINATION OF HYDROXYPROLINE [J].
BLUMENKR.N ;
ASBOEHAN.G .
CLINICAL BIOCHEMISTRY, 1974, 7 (03) :251-257
[6]  
BOGIN E, 1981, J CLIN INVEST, V67, P1215, DOI 10.1172/JCI110137
[7]  
BORLAND IA, 1985, TRANSPLANT P, V17, P1345
[8]  
COHEN RG, 1984, HEART TRANSPLANTATIO, V3, P355
[9]  
DELFOSSE L, 1975, INDIAN J BIOCHEM BIO, V12, P280
[10]   CHRONIC CYCLOSPORINE NEPHROTOXICITY - A RODENT MODEL [J].
GILLUM, DM ;
TRUONG, L ;
TASBY, J ;
MIGLIORE, P ;
SUKI, WN .
TRANSPLANTATION, 1988, 46 (02) :285-292